Process for preparation of (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt

Details for Australian Patent Application No. 2006313498 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Kishore, Kaushal; Sethi, Sachin; Sattigeri, Jitendra Anant

Agent Callinan

Pub. Number AU-B-2006313498

PCT Pub. Number WO2007/054790

Priority 2964/DEL/2005 08.11.05 IN; 2967/del/2005 08.11.05 IN; 3033/DEL/2005 14.11.05 IN

Filing date 8 November 2006

Wipo publication date 18 May 2007

Acceptance publication date 6 September 2012

International Classifications

C07D 207/34 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/054790 Priority application(s): WO2007/054790

6 September 2012 Application Accepted

  Published as AU-B-2006313498

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006313505-A valve for flowable material and a closure therefor

2006313497-Pharmaceutical combination comprising atorvastatin derivatives